Day One Biopharmaceuticals (DAWN)
(Delayed Data from NSDQ)
$14.23 USD
+0.82 (6.11%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $14.25 +0.02 (0.14%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DAWN 14.23 +0.82(6.11%)
Will DAWN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DAWN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DAWN
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q2 Loss, Tops Revenue Estimates
Day One (DAWN) In-Licenses MabCare Cancer Candidate, Stock Up
DAWN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Biotech Stock Roundup: GSK Provides Updates, Biogen to Discontinue Study & More
Here's What Could Help Day One Biopharmaceuticals, Inc. (DAWN) Maintain Its Recent Price Strength
Wall Street Analysts Think Day One Biopharmaceuticals, Inc. (DAWN) Could Surge 85%: Read This Before Placing a Bet
Other News for DAWN
Bank of America Says Buy These 3 Stocks for a Double-Digit Rally
Day One Biopharmaceuticals added to Analyst Focus List at JPMorgan
Day One Biopharmaceuticals Breaks Below 200-Day Moving Average - Notable for DAWN
Day One Biopharma draws double upgrade at BofA on Ojemda potential
Etsy downgraded, Carvana upgraded: Wall Street's top analyst calls